Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1665)
All Articles published online
|
Nov 15, 2003 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bai YR, Wu GH, Guo WJ, Wu XD, Yao Y, Chen Y, Zhou RH, Lu DQ. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: Results of feasibility study. World J Gastroenterol 2003; 9(11): 2561-2564 [PMID: 14606097 DOI: 10.3748/wjg.v9.i11.2561] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2561.htm |
| Number | Citing Articles |
| 1 |
Christopher M. Halloran, Paula Ghaneh, John P. Neoptolemos. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 972 doi: 10.1016/B978-1-4377-1454-8.00063-1
|
| 2 |
David A. Schomas, Michael T. Milano, John C. Roeske, Loren K. Mell, Arno J. Mundt. Intensity‐modulated radiotherapy and the Internet. Cancer 2004; 101(2): 412 doi: 10.1002/cncr.20359
|
| 3 |
Liv Veldeman, Indira Madani, Frank Hulstaert, Gert De Meerleer, Marc Mareel, Wilfried De Neve. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. The Lancet Oncology 2008; 9(4): 367 doi: 10.1016/S1470-2045(08)70098-6
|
| 4 |
Florence Huguet, Carla Hajj, Corrine B. Winston, Weiji Shi, Zhigang Zhang, Abraham J. Wu, Eileen M. O’Reilly, Diane L. Reidy, Peter Allen, Karyn A. Goodman. Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*. Acta Oncologica 2017; 56(3): 384 doi: 10.1080/0284186X.2016.1245862
|
| 5 |
Clifton D. Fuller, Charles R. Thomas, Adrian Wong, Sean X. Cavanaugh, Bill J. Salter, Terence S. Herman, Martin Fuss. Image-guided intensity-modulated radiation therapy for gallbladder carcinoma. Radiotherapy and Oncology 2006; 81(1): 65 doi: 10.1016/j.radonc.2006.08.013
|
| 6 |
Jerome C. Landry, Christopher G. Willett, Natia Esiashvili, Mary Koshy. Image-Guided IMRT. 2006; : 383 doi: 10.1007/3-540-30356-1_30
|
| 7 |
Andreas Kaiser, Volker Budach. Pancreatic Cancer. Recent Results in Cancer Research 2008; 177: 65 doi: 10.1007/978-3-540-71279-4_9
|
| 8 |
Michael C. Garofalo, Young Kwok, William F. Regine. The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer. Surgical Oncology Clinics of North America 2004; 13(4): 589 doi: 10.1016/j.soc.2004.06.012
|
| 9 |
Bilgehan ÇOŞKUN. Baş Boyun Radyoterapisinde Farklı Tedavi Teknikleri İle Simultane Integre Boost Yönteminin Karşılaştırılması. Marmara Fen Bilimleri Dergisi 2017; doi: 10.7240/marufbd.306338
|
| 10 |
Martin Fuss, Bill J. Salter, Terence S. Herman, Charles R. Thomas. External beam radiation therapy for hepatocellular carcinoma: Potential of intensity-modulated and image-guided radiation therapy. Gastroenterology 2004; 127(5): S206 doi: 10.1053/j.gastro.2004.09.035
|
| 11 |
Marcia Bockbrader, Edward Kim. Role of intensity-modulated radiation therapy in gastrointestinal cancer. Expert Review of Anticancer Therapy 2009; 9(5): 637 doi: 10.1586/era.09.16
|
| 12 |
Natsuo Oya, Keiko Shibuya, Takashi Sakamoto, Takashi Mizowaki, Ryuichiro Doi, Koji Fujimoto, Masayuki Imamura, Yasushi Nagata, Masahiro Hiraoka. Chemoradiotherapy in Patients with Pancreatic Carcinoma: Phase-I Study with a Fixed Radiation Dose and Escalating Doses of Weekly Gemcitabine. Pancreatology 2006; 6(1-2): 109 doi: 10.1159/000090030
|
| 13 |
Michael C. Garofalo, William F. Regine. Pancreatic Cancer. 2008; : 535 doi: 10.1007/978-0-387-69252-4_31
|
| 14 |
YoungSeok Seo, Mi-Sook Kim, SungYul Yoo, ChulKoo Cho, KwangMo Yang, HyungJun Yoo, ChulWon Choi, DongHan Lee, Jin Kim, Min Suk Kim, HyeJin Kang, YoungHan Kim. Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 2009; 75(5): 1456 doi: 10.1016/j.ijrobp.2009.01.042
|
| 15 |
Reena Engineer, Tabassum Wadasadawala, Shaesta Mehta, Umesh Mahantshetty, Nilendu Purandare, Venkatesh Rangarajan, Shyam Kishore Shrivastava. Chemoradiation for Unresectable Gall Bladder Cancer: Time to Review Historic Nihilism?. Journal of Gastrointestinal Cancer 2011; 42(4): 222 doi: 10.1007/s12029-010-9179-3
|
| 16 |
Michael Garofalo, Todd Flannery, William Regine. The case for adjuvant chemoradiation for pancreatic cancer. Best Practice & Research Clinical Gastroenterology 2006; 20(2): 403 doi: 10.1016/j.bpg.2005.11.001
|
| 17 |
Thomas B. Brunner, Susanne Merkel, Gerhard G. Grabenbauer, Thomas Meyer, Ulrich Baum, Thomas Papadopoulos, Rolf Sauer, Werner Hohenberger. Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis. International Journal of Radiation Oncology*Biology*Physics 2005; 62(4): 1021 doi: 10.1016/j.ijrobp.2004.12.018
|
| 18 |
Kevin R. Kozak, Lisa A. Kachnic, Judith Adams, Elizabeth M. Crowley, Brian M. Alexander, Harvey J. Mamon, Carlos Fernandez-Del Castillo, David P. Ryan, Thomas F. DeLaney, Theodore S. Hong. Dosimetric Feasibility of Hypofractionated Proton Radiotherapy for Neoadjuvant Pancreatic Cancer Treatment. International Journal of Radiation Oncology*Biology*Physics 2007; 68(5): 1557 doi: 10.1016/j.ijrobp.2007.02.056
|
| 19 |
Karyn A. Goodman, Carla Hajj. Role of radiation therapy in the management of pancreatic cancer. Journal of Surgical Oncology 2013; 107(1): 86 doi: 10.1002/jso.23137
|
| 20 |
Martin-Immanuel Bittner, Anca-Ligia Grosu, Thomas B. Brunner. Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer – A systematic review. Radiotherapy and Oncology 2015; 114(1): 117 doi: 10.1016/j.radonc.2014.11.043
|
| 21 |
Ruchika Gutt, Stanley L Liauw, Ralph R Weichselbaum. Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?. Nature Clinical Practice Gastroenterology & Hepatology 2009; 6(1): 38 doi: 10.1038/ncpgasthep1301
|